Renaissance Technologies’s Zosano Pharma Corporation ZSAN Stock Holding History

Renaissance Technologies’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,115	Closed	-$56K	–	4713
2022 Q1	$56K	Buy	+7,115	New	+$78.3K	﹤0.01%	3893
2021 Q4	–	Sell	-6,822	Closed	-$172K	–	4352
2021 Q3	$172K	Sell	6,822 -31,801	-82%	-$825K	﹤0.01%	3233
2021 Q2	$1.28M	Buy	+38,623	New	+$1.24M	﹤0.01%	2536
2020 Q4	–	Sell	-7,886	Closed	-$447K	–	3838
2020 Q3	$447K	Buy	+7,886	New	+$367K	﹤0.01%	2853
2017 Q1	–	Sell	-43	Closed	-$23K	–	3485
2016 Q4	$23K	Buy	+43	New	+$21.2K	﹤0.01%	3200

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Renaissance Technologies's ZSAN Position: Q2 2022 in Review

Renaissance Technologies sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 7,115 shares — an estimated $56K sold.

Renaissance Technologies first reported a position in ZSAN in Q4 2016 and held it in 5 quarters. The position peaked at $1.28M in Q2 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Renaissance Technologies reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Renaissance Technologies sold 7,115 Zosano Pharma Corporation shares in Q2 2022, an estimated $56K.
Renaissance Technologies first reported a position in Zosano Pharma Corporation in Q4 2016 and held it in 5 quarters.
Renaissance Technologies's Zosano Pharma Corporation position peaked at $1.28M in Q2 2021.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.